Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
The Independent on MSN
New blood test could show if prostate cancer treatment is failing
New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results